Double Bond Pharmaceutical International AB (XSAT:DBP B) YoY EPS Growth : 66.67% (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Double Bond Pharmaceutical International AB YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Double Bond Pharmaceutical International AB's YoY EPS Growth for the quarter that ended in Mar. 2025 was 66.67%.

Double Bond Pharmaceutical International AB's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was kr-0.01.

Double Bond Pharmaceutical International AB YoY EPS Growth Historical Data

The historical data trend for Double Bond Pharmaceutical International AB's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Double Bond Pharmaceutical International AB YoY EPS Growth Chart

Double Bond Pharmaceutical International AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

-46.32

58.28

-42.55

9.45

63.74

Double Bond Pharmaceutical International AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EPS Growth	Get a 7-Day Free Trial															50.00	-25.00	50.00	37.50	66.67

Double Bond Pharmaceutical International AB YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Double Bond Pharmaceutical International AB's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(-0.066	-	-0.182)	/	\| -0.182 \|
=	63.74 %

Double Bond Pharmaceutical International AB's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (Q: Mar. 2025 )
=	(Earnings per Share (Diluted) (Q: Mar. 2025 )	-	Earnings per Share (Diluted) (Q: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2024 )) \|
=	(-0.01	-	-0.03)	/	\| -0.03 \|
=	66.67 %

Double Bond Pharmaceutical International AB YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Double Bond Pharmaceutical International AB's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Double Bond Pharmaceutical International AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Double Bond Pharmaceutical International AB (XSAT:DBP B) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Virdings Alle 32B, Uppsala, SWE, 75450

Website

http://www.doublebp.com

Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.

Double Bond Pharmaceutical International AB Headlines

No Headlines